Medical Economics Editorial Staff

home / authors / medical-economics-editorial-staff

Articles

Medicare Part D Phase 2 Price Negotiations Target Semaglutide (Wegovy) Plus 14 More ©Corona Borealis/stock.adobe.com

Medicare Part D Phase 2 Price Negotiations Target Semaglutide (Wegovy) Plus 14 More Medications

Medical Economics Editorial Staff

January 17th 2025

Price negotiations, effective in 2027, cover drugs for diabetes, cancer, COPD, and more, aiming for substantial Medicare savings.

Latest Updated Articles

Rash in an Immunocompromised Man: Your Dx?

Published: July 25th 2014 | Updated: February 22nd 2025

Rash in an Immunocompromised Man: Your Dx?

Rash Around the Mouth of a 5-year-old Child

Published: May 10th 2016 | Updated: February 22nd 2025

Rash Around the Mouth of a 5-year-old Child

What's This "Red Spot"?

Published: January 29th 2014 | Updated: February 22nd 2025

What's This "Red Spot"?

A Ring of Firm Multiple Papules

Published: October 1st 2015 | Updated: February 22nd 2025

A Ring of Firm Multiple Papules

Hard Purple Nodules: Your Dx?

Published: September 12th 2014 | Updated: February 22nd 2025

Hard Purple Nodules: Your Dx?

What Cause of This Itchy Rash?

Published: April 11th 2014 | Updated: February 22nd 2025

What Cause of This Itchy Rash?

Editorial Board

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.